Condition: Thrombus of Left Ventricle · Sponsor: Insel Gruppe AG, University Hospital Bern
The investigators' primary objective is to assess whether a difference in the occurrence of bleeding events exist between patients with LVT treated with DOACs as compared to those treated with VKAs.
This description comes directly from the study's public registry record.
Christoph Gräni, Prof. PHD · +41 31 632 4508 · christoph.graeni@insel.ch
Always discuss trial participation with your own doctor first.
| Department of Cardiology, University Hospital Bern | Bern, Switzerland | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05028777